The technology records signals from the nerve (called electrically evoked compound action potentials or ECAPS) and adjusts stimulation levels in real time to maintain a constant evoked potential. Early clinical results indicate that closed loop neuromodulation provides patients with more consistent and accurate stimulation levels, resulting in more effective blocking of pain.
Location: Australia, New South Wales, Sydney
Employees: 201-500
Total raised: $375M
Founded date: 2013
Investors 2
| Date | Name | Website |
| - | Bioscience... | bioscience... |
| - | Action Pot... | actionpote... |
Funding Rounds 5
| Date | Series | Amount | Investors |
| 13.01.2025 | - | $100M | - |
| 17.04.2023 | Series A | $150M | - |
| 01.07.2019 | - | $75M | - |
| 31.05.2017 | Series D | $40M | Action Pot... |
| 20.02.2015 | Series B | $10M | - |
Mentions in press and media 24
| Date | Title | Description |
| 14.01.2025 | Saluda Medical Secures $100 Million to Revolutionize Pain Management | In the world of medical innovation, funding is the lifeblood that fuels progress. Saluda Medical, a Minneapolis-based company, has just secured a hefty $100 million in financing. This investment is not just a number; it represents hope for ... |
| 13.01.2025 | Saluda Medical Raises $100M in Funding | Saluda Medical, a Minneapolis, MN-based commercial-stage medical device company, raised $100M in funding. The round was led by Redmile Group, with participation from existing investors Wellington Management, TPG Life Sciences Innovation, Fi... |
| 13.01.2025 | Saluda Medical: $100 Million Of Financing Closed | Saluda Medical – a commercial-stage medical device company focused on developing treatments for chronic neurological conditions utilizing a novel closed-loop and dose-control neuromodulation platform – announced the closing of a $100 millio... |
| 04.03.2024 | Spinal Cord Stimulation Market was valued at US$2.428 billion in 2022, witnessing significant growth | The spinal cord stimulation market was valued at US$2.428 billion in 2022. The spinal cord stimulation market was valued at US$2.428 billion in 2022.” — Knowledge Sourcing IntelligenceNOIDA, UTTAR PARDESH, INDIA, March 4, 2024 /EINPresswire... |
| 18.08.2023 | Medtech Funding Expected to Pick Up In 2023 After Q1’s Low Point | In the second quarter of this year, venture capital funding for medtech companies increased slightly to $2.8 billion, up from the first quarter’s $2.5 billion, according to a new report from Pitchbook. These quarterly totals are still well ... |
| 17.04.2023 | Asia Digest: Saluda Medical raises $150m; Proto Axiom closes Series A round | Australia-based medical device manufacturer Saluda Medical has secured $150 million while biotech incubator Proto Axiom has closed its Series A funding at $15 million. Saluda Medical raises $150m Australia-based medical device manufacturer ... |
| 15.04.2023 | Saluda Medical Raises $150M in Equity Financing | Saluda Medical, an Artarmon, Australia-based medical device company, raised $150M in Equity funding. The round was led by Wellington Management. Backers included Fidelity Management & Research Company, TPG, Redmile Group, LLC, Action Po... |
| 13.04.2023 | Saluda Medical raises $150M for spinal cord stimulator to treat chronic pain | - |
| 06.07.2021 | Saluda Grade raises $100 million of platform capital via innovative securitization | NEW YORK, July 6, 2021 /PRNewswire-PRWeb/ -- Saluda Grade (SG) has completed a transformative capital raise of $100 million through a first-ever Collateralized Asset Financing (CAF) securitization. The private placement was structured and p... |
| 12.02.2021 | Saluda Medical Announces Executive Leadership Changes |
Show more